Trial Profile
Gait Analysis in Patients With MPS IVA Treated With Enzyme Replacement Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2019
Price :
$35
*
At a glance
- Drugs Elosulfase alfa (Primary)
- Indications Mucopolysaccharidosis IV
- Focus Therapeutic Use
- 15 Oct 2019 Status changed from recruiting to completed.
- 26 Feb 2014 New trial record